Anticancer agent ellipticine combined with histone deacetylase inhibitors, valproic acid and trichostatin A, is an effective DNA damage strategy in human neuroblastoma
OBJECTIVES: Valproic acid (VPA) and trichostatin A (TSA) exert antitumor activity as histone deacetylase inhibitors, whereas ellipticine action is based mainly on DNA intercalation, inhibition of topoisomerase II and formation of cytochrome P450 (CYP)- and peroxidase-mediated covalent DNA adducts. T...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
05 November 2011
|
| In: |
Neuroendocrinology letters
Year: 2011, Jahrgang: 32, Pages: 101-116 |
| ISSN: | 2354-4716 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://www.nel.edu/userfiles/articlesnew/NEL32S111A13.pdf Verlag, lizenzpflichtig, Volltext: https://www.nel.edu/anticancer-agent-ellipticine-combined-with-histone-deacetylase-inhibitors-valproic-acid-and-trichostatin-a-is-an-effective-dna-damage-strategy-in-human-neuroblastoma-813/ 
|
| Verfasserangaben: | Jitka Poljakova, Jana Hrebackova, Marketa Dvorakova, Michaela Moserova, Tomas Eckschlager, Jan Hrabeta, Marketa Göttlicherova, Barbora Kopejtkova, Eva Frei, Rene Kizek, Marie Stiborova |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1830261827 | ||
| 003 | DE-627 | ||
| 005 | 20230710095220.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230103s2011 xx |||||o 00| ||eng c | ||
| 035 | |a (DE-627)1830261827 | ||
| 035 | |a (DE-599)KXP1830261827 | ||
| 035 | |a (OCoLC)1389738526 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Poljakova, Jitka |e VerfasserIn |0 (DE-588)1277106479 |0 (DE-627)1830263862 |4 aut | |
| 245 | 1 | 0 | |a Anticancer agent ellipticine combined with histone deacetylase inhibitors, valproic acid and trichostatin A, is an effective DNA damage strategy in human neuroblastoma |c Jitka Poljakova, Jana Hrebackova, Marketa Dvorakova, Michaela Moserova, Tomas Eckschlager, Jan Hrabeta, Marketa Göttlicherova, Barbora Kopejtkova, Eva Frei, Rene Kizek, Marie Stiborova |
| 264 | 1 | |c 05 November 2011 | |
| 300 | |a 16 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 03.01.2023 | ||
| 520 | |a OBJECTIVES: Valproic acid (VPA) and trichostatin A (TSA) exert antitumor activity as histone deacetylase inhibitors, whereas ellipticine action is based mainly on DNA intercalation, inhibition of topoisomerase II and formation of cytochrome P450 (CYP)- and peroxidase-mediated covalent DNA adducts. This is the first report on the molecular mechanism of combined treatment of human neuroblastoma UKF-NB-3 and UKF-NB-4 cells with these compounds. - METHODS: HPLC with UV detection was employed for the separation and characterization of ellipticine metabolites formed by microsomes and peroxidases. Covalent DNA modifications by ellipticine in neuroblastoma cells and in incubations with microsomes and peroxidases were detected by 32P-postlabeling. Expression of CYP enzymes, peroxidases and cytochrome b5 was examined by Western blot. - RESULTS: The cytotoxicity of ellipticine to neuroblastomas was increased by pre-treating these cells with VPA or TSA. A higher sensitivity of cells to ellipticine correlated with an increase in formation of covalent ellipticine-derived DNA adducts in these cells. To evaluate the mechanisms of this finding, we investigated the modulation by VPA and TSA of CYP- and peroxidase-mediated ellipticine-derived DNA adduct formation in vitro. The effects of ellipticine in the presence of VPA and TSA on expression of CYPs and peroxidases relevant for ellipticine activation and levels of cytochrome b5 and P-glycoprotein in neuroblastoma cells were also investigated. Based on these studies, we attribute most of the enhancing effects of VPA and TSA on ellipticine cytotoxicity to enhanced ellipticine-DNA adduct formation caused by an increase in levels of cytochrome b5, CYP3A4 and CYP1A1 in neuroblastoma cells. A lower sensitivity of UKF-NB-4 cells to combined effects of ellipticine with VPA and TSA than of UKF-NB-3 cells is also attributable to high levels of P-glycoprotein expressed in this cell line. - CONCLUSION: The results found here warrant further studies and may help in the design of new protocols geared to the treatment of high risk neuroblastomas. | ||
| 650 | 4 | |a Animals | |
| 650 | 4 | |a Antineoplastic Combined Chemotherapy Protocols | |
| 650 | 4 | |a Brain Neoplasms | |
| 650 | 4 | |a DNA Damage | |
| 650 | 4 | |a Dose-Response Relationship, Drug | |
| 650 | 4 | |a Drug Evaluation, Preclinical | |
| 650 | 4 | |a Ellipticines | |
| 650 | 4 | |a Histone Deacetylase Inhibitors | |
| 650 | 4 | |a Humans | |
| 650 | 4 | |a Hydroxamic Acids | |
| 650 | 4 | |a Microsomes, Liver | |
| 650 | 4 | |a Models, Biological | |
| 650 | 4 | |a Neuroblastoma | |
| 650 | 4 | |a Rats | |
| 650 | 4 | |a Treatment Outcome | |
| 650 | 4 | |a Tumor Cells, Cultured | |
| 650 | 4 | |a Valproic Acid | |
| 700 | 1 | |a Hrebackova, Jana |e VerfasserIn |4 aut | |
| 700 | 1 | |a Dvorakova, Marketa |e VerfasserIn |4 aut | |
| 700 | 1 | |a Moserova, Michaela |e VerfasserIn |4 aut | |
| 700 | 1 | |a Eckschlager, Tomas |e VerfasserIn |4 aut | |
| 700 | 1 | |a Hrabeta, Jan |e VerfasserIn |4 aut | |
| 700 | 1 | |a Göttlicherova, Marketa |e VerfasserIn |4 aut | |
| 700 | 1 | |a Kopejtkova, Barbora |e VerfasserIn |4 aut | |
| 700 | 1 | |a Frei, Eva |d 1950- |e VerfasserIn |0 (DE-588)112546450X |0 (DE-627)880025433 |0 (DE-576)483423068 |4 aut | |
| 700 | 1 | |a Kizek, Rene |e VerfasserIn |4 aut | |
| 700 | 1 | |a Stiborova, Marie |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Neuroendocrinology letters |d Munsbach : Maghira & Maas, 1997 |g 32(2011), Suppl 1, Seite 101-116 |h Online-Ressource |w (DE-627)35419495X |w (DE-600)2088398-5 |w (DE-576)32953839X |x 2354-4716 |7 nnas |a Anticancer agent ellipticine combined with histone deacetylase inhibitors, valproic acid and trichostatin A, is an effective DNA damage strategy in human neuroblastoma |
| 773 | 1 | 8 | |g volume:32 |g year:2011 |g supplement:Suppl 1 |g pages:101-116 |g extent:16 |a Anticancer agent ellipticine combined with histone deacetylase inhibitors, valproic acid and trichostatin A, is an effective DNA damage strategy in human neuroblastoma |
| 856 | 4 | 0 | |u https://www.nel.edu/userfiles/articlesnew/NEL32S111A13.pdf |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://www.nel.edu/anticancer-agent-ellipticine-combined-with-histone-deacetylase-inhibitors-valproic-acid-and-trichostatin-a-is-an-effective-dna-damage-strategy-in-human-neuroblastoma-813/ |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20230103 | ||
| 993 | |a Article | ||
| 994 | |a 2011 | ||
| 998 | |g 112546450X |a Frei, Eva |m 112546450X:Frei, Eva |d 140000 |e 140000PF112546450X |k 0/140000/ |p 9 | ||
| 999 | |a KXP-PPN1830261827 |e 4243137943 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"recId":"1830261827","language":["eng"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"note":["Gesehen am 03.01.2023"],"title":[{"title_sort":"Anticancer agent ellipticine combined with histone deacetylase inhibitors, valproic acid and trichostatin A, is an effective DNA damage strategy in human neuroblastoma","title":"Anticancer agent ellipticine combined with histone deacetylase inhibitors, valproic acid and trichostatin A, is an effective DNA damage strategy in human neuroblastoma"}],"person":[{"family":"Poljakova","given":"Jitka","display":"Poljakova, Jitka","roleDisplay":"VerfasserIn","role":"aut"},{"display":"Hrebackova, Jana","roleDisplay":"VerfasserIn","role":"aut","family":"Hrebackova","given":"Jana"},{"display":"Dvorakova, Marketa","roleDisplay":"VerfasserIn","role":"aut","family":"Dvorakova","given":"Marketa"},{"role":"aut","display":"Moserova, Michaela","roleDisplay":"VerfasserIn","given":"Michaela","family":"Moserova"},{"given":"Tomas","family":"Eckschlager","role":"aut","roleDisplay":"VerfasserIn","display":"Eckschlager, Tomas"},{"given":"Jan","family":"Hrabeta","role":"aut","roleDisplay":"VerfasserIn","display":"Hrabeta, Jan"},{"display":"Göttlicherova, Marketa","roleDisplay":"VerfasserIn","role":"aut","family":"Göttlicherova","given":"Marketa"},{"roleDisplay":"VerfasserIn","display":"Kopejtkova, Barbora","role":"aut","family":"Kopejtkova","given":"Barbora"},{"given":"Eva","family":"Frei","role":"aut","display":"Frei, Eva","roleDisplay":"VerfasserIn"},{"given":"Rene","family":"Kizek","role":"aut","display":"Kizek, Rene","roleDisplay":"VerfasserIn"},{"family":"Stiborova","given":"Marie","roleDisplay":"VerfasserIn","display":"Stiborova, Marie","role":"aut"}],"relHost":[{"physDesc":[{"extent":"Online-Ressource"}],"name":{"displayForm":["Society for Integrated Sciences"]},"origin":[{"publisherPlace":"Munsbach ; Stockholm","dateIssuedKey":"1997","publisher":"Maghira & Maas","dateIssuedDisp":"1997-"}],"id":{"zdb":["2088398-5"],"eki":["35419495X"],"issn":["2354-4716"]},"type":{"media":"Online-Ressource","bibl":"periodical"},"disp":"Anticancer agent ellipticine combined with histone deacetylase inhibitors, valproic acid and trichostatin A, is an effective DNA damage strategy in human neuroblastomaNeuroendocrinology letters","note":["Frühere Jahrgänge online nicht mehr verfügbar","Gesehen am 26.04.18"],"recId":"35419495X","language":["eng"],"pubHistory":["Nachgewiesen 18.1997 -"],"part":{"extent":"16","text":"32(2011), Suppl 1, Seite 101-116","volume":"32","pages":"101-116","year":"2011"},"titleAlt":[{"title":"NEL"}],"title":[{"subtitle":"NEL ; including psychoneuroimmunology, neuropsychopharmacology, reproductive medicine, chronobiology and human ethology","title":"Neuroendocrinology letters","title_sort":"Neuroendocrinology letters"}]}],"physDesc":[{"extent":"16 S."}],"id":{"eki":["1830261827"]},"origin":[{"dateIssuedKey":"2011","dateIssuedDisp":"05 November 2011"}],"name":{"displayForm":["Jitka Poljakova, Jana Hrebackova, Marketa Dvorakova, Michaela Moserova, Tomas Eckschlager, Jan Hrabeta, Marketa Göttlicherova, Barbora Kopejtkova, Eva Frei, Rene Kizek, Marie Stiborova"]}} | ||
| SRT | |a POLJAKOVAJANTICANCER0520 | ||